Ozempic, a popular weight-loss drug, is causing unexpected side effects like “Ozempic mouth,” “Ozempic face,” “Ozempic feet,” and “Ozempic butt,” due to rapid fat loss and skin sagging.

The battle between weight-loss drugs continues. While studies show semaglutide (sold under the brand names Ozempic and Wegovy) can improve your dementia risk and prevent Alzheimer's, additional research proves that tirzepatide (Mounjaro and Zepbound) is actually more effective for weight loss.

Semaglutide — known by brand names Ozempic and Wegovy — works in the brain to impact satiety. Over the past two years, the popularity of weekly injections for weight loss has soared. As of 2024, one in eight adults in the United States has taken a GLP-1 medication (glucagon-like peptide-1 receptor agonists) like Ozempic.